Exactech Launches Octane® Elevate Peek Spacer System For Lumbar Interbody Fusion Procedures
November 11 2014 - 7:56AM
Business Wire
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder, spine and
biologic materials, announces that its spine division has launched
Octane® Elevate, a Poly Ether Ether Ketone (PEEK) spacer system, at
the North American Spine Society Annual Meeting (NASS).
With the introduction of Octane Elevate, an innovative,
self-distracting lumbar fusion device, surgeons can restore disc
height while addressing various anatomical conditions and degrees
of degeneration. Octane Elevate is designed to be implanted with
less force, potentially reducing incidence of vertebrae and nerve
damage. A unique feature of the product’s design and
instrumentation allows surgeons to backfill the interbody spacer
with autogenous bone graft, which is designed to aid in fusion.
Octane Elevate’s versatility is highlighted through its multiple
footprint options and heights available in 1mm increments.
“Exactech is focused on developing solutions to make spine
surgery less invasive and less traumatic for the patient, and to
provide the surgeon with tools that create the opportunity for
better and repeatable results,” said Bruce Thompson, Sr. Vice
President, General Manager of Spine and Biologics at Exactech.
“Octane Elevate is a unique product that we hope will be successful
in achieving both goals.”
Created with a goal of simple, intuitive instrumentation, Octane
Elevate was designed in collaboration with Charley Gordon, MD to
minimize learning curve and surgical time, as well as offer a wide
range of interbody options accommodating various anatomical
conditions and pathologies.
“I have been very pleased with my clinical results using the
Octane Elevate cage. This device is unique in that it is
radiolucent and allows a surgeon to place a right sized implant
into the intradiscal space from a posterior approach,” said Dr.
Gordon. “The cage incorporates a large graft window which
facilitates substantial placement of bone and overall I've been
quite happy with our early clinical results.”
With a successful pilot launch, the addition of Octane Elevate
marks another milestone in the continued development of innovative
products by Exactech Spine. The system rounds out Exactech’s
lumbar interbody offerings enabling surgeons to perform lumbar
interbody fusions with a wide range of options.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
Exactech, Inc.Investor contactsJody Phillips, 352-377-1140Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888E-mail: exactech@hawkassociates.com
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2024 to May 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From May 2023 to May 2024